• In February 2026, RXO, Inc. launched its Middle Mile Solutions service, offering an integrated "dock-to-door" logistics network that links first-, middle-, and last-mile transportation with warehousing, kitting, and reverse logistics, all powered by its RXO Connect® tech platform for item-level visibility and proactive alerts.
• This move effectively positions RXO as a single-source logistics partner for shippers seeking to simplify vendor relationships while tightening control over complex, multi-stage freight flows.
• Next, we’ll examine how RXO’s push into integrated middle-mile solutions, against rising transportation costs, reshapes the company’s investment narrative.

Capitalize on the AI infrastructure supercycle with our selection of the 35 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.

What Is RXO's Investment Narrative?

For RXO to make sense in a portfolio, you need to believe that its asset-light brokerage model, paired with the RXO Connect platform, can convert scale and data into better pricing power and more efficient freight flows despite recent losses and a weak share price. The new Middle Mile Solutions launch fits this story by deepening RXO’s role in customers’ supply chains and potentially giving it more touchpoints to spread technology and service costs across. In the near term, though, the stock still screens as a turnaround idea: key catalysts remain any signs of volume improvement, better margins as transportation costs shift, and clearer progress toward profitability after the recent goodwill impairment. The largest risks are execution missteps on the middle-mile build-out and an already stretched balance sheet.

However, RXO’s leverage and past erosion in returns on capital are hard risks to ignore. Despite retreating, RXO's shares might still be trading above their fair value and there could be some more downside. Discover how much.

Exploring Other Perspectives

Three Simply Wall St Community fair value estimates for RXO span roughly US$15.89 to US$34.65, underscoring how differently private investors view its upside. Set that against RXO’s recent losses and rising financial risk, and it is clear you are weighing growth initiatives like Middle Mile Solutions against a business still working to stabilize performance.

Explore 3 other fair value estimates on RXO - why the stock might be worth just $15.89!

Decide For Yourself

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your RXO research is our analysis highlighting 3 key rewards that could impact your investment decision.
• Our free RXO research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate RXO's overall financial health at a glance.

Contemplating Other Strategies?

Our top stock finds are flying under the radar-for now. Get in early:

• Invest in the nuclear renaissance through our list of 85 elite nuclear energy infrastructure plays powering the global AI revolution.
• Find 46 companies with promising cash flow potential yet trading below their fair value.
• AI is about to change healthcare. These 32 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.